Use of Auto-Injector for Methotrexate Subcutaneous Self-Injections: High Satisfaction Level and Good Compliance in SELF-I Study, a Randomized, Open-Label, Parallel Group Study

ConclusionsAlthough this study did not demonstrate non-inferiority of AI versus PFS, compliance was excellent in the two groups, and AI, which was preferred by patients, is a valuable alternative to PFS for administration of MTX.Trial RegistrationClinicalTrials.gov identifier, NCT02553018.FundingNordic Pharma SAS.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research